BMX and central nervous system cancer: NBM-BMX (BMX) enhancer the sensitiveness at TMZ in glioma cells by inhibiting the activity of the β-catenin/c-Myc/SOX2 signaling pathway. (NCT06012695; NCT03726294; NCT03808870)